Functional Interaction between Angiotensin II Receptor Type 1 and Chemokine (C-C Motif) Receptor 2 with Implications for Chronic Kidney Disease

被引:37
|
作者
Ayoub, Mohammed Akli [1 ,2 ]
Zhang, Yuan [3 ]
Kelly, Robyn S. [3 ]
See, Heng B. [1 ,2 ]
Johnstone, Elizabeth K. M. [1 ,2 ]
McCall, Elizabeth A. [4 ]
Williams, James H. [4 ]
Kelly, Darren J. [3 ]
Pfleger, Kevin D. G. [1 ,2 ,4 ]
机构
[1] QEII Med Ctr, Harry Perkins Inst Med Res, Mol Endocrinol & Pharmacol, Nedlands, WA, Australia
[2] Univ Western Australia, Med Res Ctr, Crawley, WA, Australia
[3] Univ Melbourne, St Vincents Hosp, Dept Med, Melbourne, Vic, Australia
[4] Dimerix Biosci Ltd, Nedlands, WA, Australia
来源
PLOS ONE | 2015年 / 10卷 / 03期
基金
澳大利亚研究理事会; 澳大利亚国家健康与医学研究理事会;
关键词
RESONANCE ENERGY-TRANSFER; KAPPA-B ACTIVATION; MACROPHAGE INFILTRATION; RENAL INJURY; EXPRESSION; RAT; HETEROMERIZATION; RECRUITMENT; INHIBITION; APOPTOSIS;
D O I
10.1371/journal.pone.0119803
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Understanding functional interactions between G protein-coupled receptors is of great physiological and pathophysiological importance. Heteromerization provides one important potential mechanism for such interaction between different signalling pathways via macromolecular complex formation. Previous studies suggested a functional interplay between angiotensin II receptor type 1 (AT(1)) and Chemokine (C-C motif) Receptor 2 (CCR2). However the molecular mechanisms are not understood. We investigated AT(1)-CCR2 functional interaction in vitro using bioluminescence resonance energy transfer in HEK293 cells and in vivo using subtotal-nephrectomized rats as a well-established model for chronic kidney disease. Our data revealed functional heteromers of these receptors resulting in CCR2-G alpha i1 coupling being sensitive to AT(1) activation, as well as apparent enhanced beta-arrestin2 recruitment with agonist co-stimulation that is synergistically reversed by combined antagonist treatment. Moreover, we present in vivo findings where combined treatment with AT(1)- and CCR2-selective inhibitors was synergistically beneficial in terms of decreasing proteinuria, reducing podocyte loss and preventing renal injury independent of blood pressure in the subtotal-nephrectomized rat model. Our findings further support a role for G protein-coupled receptor functional heteromerization in pathophysiology and provide insights into previous observations indicating the importance of AT(1)-CCR2 functional interaction in inflammation, renal and hypertensive disorders.
引用
收藏
页数:22
相关论文
共 50 条
  • [1] Interaction between epidermal growth factor receptor and C-C motif chemokine receptor 2 in the ovulatory cascade
    Conte, J. G.
    Tellechea, M. L.
    Park, B.
    Ballerini, M. G.
    Jaita, G.
    Peluffo, M. C.
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2023, 11
  • [2] Differential expression and functional roles of chemokine (C-C motif) ligand 23 and its receptor chemokine (C-C motif) receptor type 1 in the uterine endometrium during early pregnancy in pigs
    Jeong, Wooyoung
    Bae, Hyocheol
    Lim, Whasun
    Bazer, Fuller W.
    Song, Gwonhwa
    DEVELOPMENTAL AND COMPARATIVE IMMUNOLOGY, 2017, 76 : 316 - 325
  • [3] Renin angiotensin system molecules and chemokine (C-C motif) ligand 2 (CCL2) in chronic kidney disease patients
    Gomes Schettini, Isabella Viana
    Faria, Debora Vargas
    Nogueira, Leilismara Sousa
    Otoni, Alba
    Simoes E Silva, Ana Cristina
    Alves Rios, Danyelle Romana
    JORNAL BRASILEIRO DE NEFROLOGIA, 2022, 44 (01): : 19 - 25
  • [4] C-C motif chemokine receptor 2 as a novel intermediate in the ovulatory cascade
    Jaworski, J. P.
    Urrutia, M.
    Dascal, E.
    Jaita, G.
    Peluffo, M. C.
    MOLECULAR HUMAN REPRODUCTION, 2020, 26 (05) : 289 - 300
  • [5] Potentials of C-C motif chemokine 2-C-C chemokine receptor type 2 blockers including propagermanium as anticancer agents
    Yumimoto, Kanae
    Sugiyama, Shigeaki
    Mimori, Koshi
    Nakayama, Keiichi I.
    CANCER SCIENCE, 2019, 110 (07) : 2090 - 2099
  • [6] C-C chemokine receptor 2 and C-C chemokine receptor 5 genotypes in patients treated for chronic hepatitis C virus infection
    Dorak, MT
    Folayan, GO
    Niwas, S
    van Leeuwen, DJ
    Yee, LJ
    Tang, JM
    Kaslow, RA
    IMMUNOLOGIC RESEARCH, 2002, 26 (1-3) : 167 - 175
  • [7] C-C chemokine receptor 2 and C-C chemokine receptor 5 genotypes in patients treated for chronic hepatitis C virus infection
    M. Tevfik Dorak
    Gbolahan O. Folayan
    Santosh Niwas
    Dirk J. van Leeuwen
    Leland J. Yee
    Jianning Tang
    Richard A. Kaslow
    Immunologic Research, 2002, 26 : 167 - 175
  • [8] C-C motif chemokine ligand 2/C-C motif chemokine receptor 2 pathway as a therapeutic target and regulatory mechanism for spinal cord injury
    Wang, Xiangzi
    Niu, Xiaofei
    Wang, Yingkai
    Liu, Yang
    Yang, Cheng
    Chen, Xuyi
    Qi, Zhongquan
    NEURAL REGENERATION RESEARCH, 2025, 20 (08) : 2231 - 2244
  • [9] C-C motif chemokine ligand 2/C-C receptor 2 is associated with glioma recurrence and poor survival
    Yang, Qiuan
    Zhang, Junpeng
    Zhang, Xin
    Miao, Lifeng
    Zhang, Wei
    Jiang, Zheng
    Zhou, Wei
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2021, 21 (06)
  • [10] Cloning and functional characterization of the rabbit C-C chemokine receptor 2
    Lu, DS
    Yuan, XJ
    Evans, RJ
    Pappas, AT
    Wang, H
    Su, EW
    Hamdouchi, C
    Venkataraman, C
    BMC IMMUNOLOGY, 2005, 6 (1)